WASHINGTON, April 13 /PRNewswire/ -- The Medical Device Manufacturers Association (MDMA) recently welcomed two new members to its Board of Directors.
W. Bradford Gary, vice president, Government Operations, for Allergan Inc., in Irvine, CA, rejoins MDMA's Board, having previously served from 1996 to 2002. Casey McGlynn, a partner and chairman, Life Sciences Group, at Wilson Sonsini Goodrich & Rosati, in Palo Alto, CA, also was elected to the Board.
"We are pleased to have Casey McGlynn join MDMA's board, in addition to welcoming Brad Gary back to MDMA," said Mark Leahey, Executive Director of MDMA. "Casey and Brad each offer unique insight into the opportunities and challenges facing the innovative and entrepreneurial sector of the medical technology industry. Their expertise will help ensure that MDMA is able to better serve its members and industry."
"I am very happy to be joining the MDMA board," McGlynn said. "I think the organization performs a vital mission in protecting the interests of small medical device companies. These emerging medical device companies are responsible for much of the technological innovation that is improving the medical treatments available to all of us."
"I look forward to rejoining the Board of MDMA after a several-year absence," Gary said. "The 'can-do,' innovative spirit of the medical device industry is well represented by MDMA. Whether it is FDA reform or CMS payment policy, MDMA is the lead element for presenting our views to Congress and the Executive Branch."
Early in his career, Mr. Gary served on the staff of former U.S. Rep. Les Aspin (D-WI; 1971-1993). He also served as U.S. Senate staff. In government service, Mr. Gary was a professional staff member specializing in national security matters. Prior to his appointment with Allergan in 1991, he was a senior executive with 3M Company, Anheuser-Busch Companies, Baxter International, and the Warner-Lambert Company. Mr. Gary graduated from George Washington University and was a Congressional Fellow in the university's Political Science Department. He did additional graduate work at George Washington and at Cambridge University in the United Kingdom.
Mr. McGlynn joined Wilson Sonsini Goodrich & Rosati in 1978 and is a member of the firm's Policy Committee. Mr. McGlynn's practice focuses on the organization, funding, and corporate representation of companies in the information technology, life sciences, and telecommunications industries. He is a nationally recognized leader in the representation of start-up and growth technology companies. He received both his JD and BA degrees with highest honors from Santa Clara University. He was recognized in the 2005 edition of Chambers USA: America's Leading Business Lawyers and was selected for inclusion in the 2006 edition of Best Lawyers in America.
Other MDMA board members include Wayne Barlow of Wescor, Inc.; Stan Bauman of Immuno-Mycologics, Inc.; Nancy Briefs of Percardia, Inc. (Board Chair); Chris Chavez of Advanced Neuromodulation Systems; Kelvyn Cullimore, Jr. of Dynatronics Corporation; Ryan Drant of New Enterprise Associates; Ron Earle, board member emeritus; Kenneth Hayes of Radiant Medical, Inc.; Eamonn Hobbs of AngioDynamics, Inc.; Joe Kiani of Masimo Corporation; Guy Nohra of Alta Partners; Paul Touhey of Fujirebio Diagnostics, Inc.; Thomas Thompson of Neuro Resource Group; Russ Trenary of Advanced Medical Optics; and Mark Wan of Three Arch Partners.
The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C., that represents and serves the innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.
Medical Device Manufacturers AssociationCONTACT: Christopher Delporte, Director of Communications and MemberRelations of Medical Device Manufacturers Association, +1-202-349-7173
Web site: http://www.medicaldevices.org/
